Here is my analysis.
Pros
- Humana has been doing the Medicare business for a long time.
- Has a necessary infrastructure developed to serve the customer
Cons
- A company or institution with a rigid system for making decisions and enacting changes
- Incompetent leadership at most levels
What Humana needs badly to turn around before it can attract investors
- Cut the cost significantly and run as a startup
- Humana needs to reduce the cost and provide a better service
- Win customer confidence by delivering better value for the service
- Why would a company need 67400 employees to deliver the same services? They significantly have to reduce their costs by reducing the employee count.
- Make major changes to the leadership at all levels.
- Bring in young and bold people in leadership with a customer-centric perspective.
Analyst Downgrades
- UBS analyst Kevin Caliendo Lowered the price target - From $380 to $250
- Piper Sandler analyst Jessica Tassan - from $392 to $274
- Deutsche Bank analyst George Hill from $349 to $250
- Oppenheimer analyst Michael Wiederhorn from $400 to $280
- BofA lowered Price Target to $247 From $376
- Leerink Partners from $400 to $250
- Stephens from $400 to $250
- Wolfe Research price target - $342 From $400 (BEFORE the NEWS - 12 days ago)
- RBC price target - $385 From $400 (BEFORE the NEWS - 30 days ago)
- JPMorgan Adjusts Price Target on Humana to $396 From $332
And many more downgrades even before the news.
Overall, the health sector is getting softer (Sector Warning)
Some news (Humana specific warnings)
BofA- Humana's 2026 Results Could Take 'Significant' Hit From Potential Medicare Star Rating (For People who don't know why their is a significant downfall)
CONCLUSION
- Humana stock and overall Healthcare sector is going through lot of uncertainties.
- USA Election is adding more uncertainties
- Humana is significantly overvalued since their star rating is cut to 3.5. This will result in loss of lot of business overall.